223 related articles for article (PubMed ID: 25990246)
21. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
Thimsen V; John N; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Knosp E; Losa M; Buslei R; Hölsken A
Sci Rep; 2017 Nov; 7(1):15856. PubMed ID: 29158570
[TBL] [Abstract][Full Text] [Related]
22. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
Larsen AB; Stockhausen MT; Poulsen HS
Cell Signal; 2010 Apr; 22(4):636-44. PubMed ID: 19948216
[TBL] [Abstract][Full Text] [Related]
23. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
Liu JF; Tsao YT; Hou CH
Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
[TBL] [Abstract][Full Text] [Related]
24. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.
Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):721-32. PubMed ID: 25611703
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Cancer Gene Ther; 2018 Oct; 25(9-10):227-239. PubMed ID: 29681617
[TBL] [Abstract][Full Text] [Related]
27. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract][Full Text] [Related]
28. EGFR signaling regulates tumor cell migration in craniopharyngiomas.
Hölsken A; Gebhardt M; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Clin Cancer Res; 2011 Jul; 17(13):4367-77. PubMed ID: 21562037
[TBL] [Abstract][Full Text] [Related]
29. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
Gilbertson RJ; Bentley L; Hernan R; Junttila TT; Frank AJ; Haapasalo H; Connelly M; Wetmore C; Curran T; Elenius K; Ellison DW
Clin Cancer Res; 2002 Oct; 8(10):3054-64. PubMed ID: 12374672
[TBL] [Abstract][Full Text] [Related]
30. Proteomics in pediatric cystic craniopharyngioma.
Massimi L; Martelli C; Caldarelli M; Castagnola M; Desiderio C
Brain Pathol; 2017 May; 27(3):370-376. PubMed ID: 28414889
[TBL] [Abstract][Full Text] [Related]
31. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
32. Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma.
Chen M; Zheng SH; Liu Y; Shi J; Qi ST
J Neurol Sci; 2016 Jan; 360():49-54. PubMed ID: 26723972
[TBL] [Abstract][Full Text] [Related]
33. ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.
Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
J Surg Res; 2008 May; 146(1):43-8. PubMed ID: 17631905
[TBL] [Abstract][Full Text] [Related]
34. Lck is a key target of imatinib and dasatinib in T-cell activation.
Lee KC; Ouwehand I; Giannini AL; Thomas NS; Dibb NJ; Bijlmakers MJ
Leukemia; 2010 Apr; 24(4):896-900. PubMed ID: 20147973
[No Abstract] [Full Text] [Related]
35. MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and
Li M; Zhou L; Li S; Fang L; Yang L; Wu X; Yang C; Bao Y; Lan S; Tong Z; Zheng S; Tang B; Zeng E; Xie S; Chen C; Hong T
Oncol Lett; 2021 Jul; 22(1):536. PubMed ID: 34084216
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.
Apps JR; Martinez-Barbera JP
Neurosurg Focus; 2016 Dec; 41(6):E4. PubMed ID: 27903120
[TBL] [Abstract][Full Text] [Related]
37. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.
Addo-Yobo SO; Straessle J; Anwar A; Donson AM; Kleinschmidt-Demasters BK; Foreman NK
J Neuropathol Exp Neurol; 2006 Aug; 65(8):769-75. PubMed ID: 16896310
[TBL] [Abstract][Full Text] [Related]
38. Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma.
Zou YF; Zhang SY; Li LW; Jing K; Xia L; Sun CX; Wu B
Medicine (Baltimore); 2022 Sep; 101(37):e30278. PubMed ID: 36123899
[TBL] [Abstract][Full Text] [Related]
39. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
[TBL] [Abstract][Full Text] [Related]
40. Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment.
Hölsken A; Buslei R
Brain Pathol; 2017 May; 27(3):358-363. PubMed ID: 28414888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
